At a glance
ClinicalIndex Comparison RecordN/ACompleted· 14 enrolled
Drug / intervention
Trainingbehavioral
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Clinical Trial, Investigating the Effect of a Home-based Moderate Intensity Training Program on Oxidative Capacity and Hemodynamics in Patients With Truncating Genetic Variants in TTN.
In Brief
A clinical study evaluating Training for Cardiomyopathies and 2 related conditions. Completed, enrolled 14 participants across 1 site.
Detailed Summary
The aim is to investigate the effect of an 8-week moderate-intensity exercise program on aerobic fitness and cardiac contractility in patients with truncations of the sarcomeric protein titin.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsCardiomyopathies, Truncation Mutation, TTN
CountriesDenmark
Collaborators--
Timeline
N/ACompletedFinished
20222023202420252026
First PostedJan 2022
Enrollment StartFeb 2022
Primary CompletionSep 2022
TodayJul 2026
First PostedJan 6, 2022
Enrollment StartFeb 14, 2022
Primary CompletionSep 21, 2022
TodayJul 2, 2026
Enrollment to primary: 7 monthsPosted 4.5 years ago
Interventions
Trainingbehavioral
In the 8-week training period, participants will have three training sessions with a duration of 30 minutes at 70% of VO2peak per week.